M. K. Proteins Ltd

M. K. Proteins Ltd's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, along with the auditors' report and a declaration regarding unmodified opinion. The board also approved the re-appointment of M/s. K. K. Sinha & Associates as Cost Auditors and M/s. Jayant Bansal & Co. as Internal Auditor for the financial year 2026-27. Additionally, related party transactions for the half-year ended March 31, 2026, were considered.

M. K. Proteins Ltd's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, along with related statements and reports. They also re-appointed M/s. K. K. Sinha & Associates as Cost Auditors and M/s. Jayant Bansal & Co. as Internal Auditor for the financial year 2026-27. The board meeting was held on May 29, 2026, commencing at 03:30 P.M. and concluding at 04:30 P.M.

M. K. Proteins Ltd's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, along with the statement of cash flow and statement of assets and liabilities. The board also re-appointed M/s. K. K. Sinha & Associates as Cost Auditors and M/s. Jayant Bansal & Co. as Internal Auditor for the financial year 2026-27. The meeting commenced at 03:30 P.M. and concluded at 04:30 P.M.

M. K. Proteins Ltd has scheduled a Board of Directors meeting on May 29, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026. The board will also consider the re-appointment of M/s. K. K. Sinha & Associates as Cost Auditors and M/s. Jayant Bansal & Co. as Internal Auditor for the financial year 2026-27. The trading window will re-open 48 hours after the declaration of the financial results.

M. K. Proteins Ltd. has approved the Un-Audited Financial Results for the quarter and nine months ended 31st December, 2025. The results were reviewed by the Audit Committee and approved by the Board of Directors. The company is engaged in the manufacturing of Vegetable Refined oil and there is no separate reportable segment. The results have been reviewed by the Statutory Auditor as required under regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

M. K. Proteins Ltd. announced its un-audited financial results for the quarter and nine months ended 31st December 2025. The company's revenue from operations stands at 8,955.83 Lacs for the quarter and 23,707.60 Lacs for the nine months period. The profit before tax for the quarter is 767.12 Lacs and 1,546.97 Lacs for the nine months period. The company's earnings per equity share for the quarter is 143.08 and 74.67 for the nine months period. The company is engaged in the manufacturing of vegetable refined oil and there is no separate reportable segment.

M. K. Proteins Ltd has announced that its Board of Directors will meet on February 13, 2026, to consider and approve the un-audited financial results for the quarter ended 31st December 2025. The meeting will also discuss any other items with the chairman's permission. Furthermore, in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for prevention of Insider Trading, the 'Trading Window' for trading in Equity Shares of the Company will re-open after 48 hours from the declaration of the aforesaid Un-audited Financial Results.

M. K. Proteins Ltd. has announced the closure of the trading window for all employees, directors, key managerial personnel, promoters, designated persons, and their immediate relatives or any other insiders. The closure will be in effect from Thursday, 15th January, 2026 until 48 hours after the declaration of the un-audited financial results for the quarter ended 31st December, 2025. The date of the board meeting for the consideration of these results will be intimated in due course. This action is in accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for Prohibition of Insider Trading.

M. K. Proteins Ltd. has announced its un-audited financial results for the quarter and half year ended September 30, 2025. The total revenue for the half year stood at INR 3,390.17 Lacs, with a net profit of INR 570.49 Lacs. The company's earnings per equity share for continuing operations were INR 0.30. The Statutory Auditors have reviewed the results.

M. K. Proteins Ltd. has submitted its un-audited financial results for the quarter and half year ended on September 30, 2025. The company's revenue (net) for H1 2025 stands at INR 3,243.03 Lacs, with a profit before tax of INR 570.49 Lacs. The EPS for continuing operations is INR 0.30. The total assets of the company amount to INR 8,001.90 Lacs as of September 30, 2025.